Cargando…
Overexpression of NAC1 confers drug resistance via HOXA9 in colorectal carcinoma cells
Colorectal carcinoma (CRC) is one of the most common types of malignancy worldwide. Recently, neoadjuvant chemotherapy has become an important treatment strategy for CRC. However, treatment frequently fails due to the development of chemoresistance, which is a major obstacle for positive prognosis....
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547960/ https://www.ncbi.nlm.nih.gov/pubmed/28713930 http://dx.doi.org/10.3892/mmr.2017.6986 |